Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aolanti dose-ranging placebo-controlled study in functional dyspepsia
ISRCTN10266781Phase 2Completed
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Total Flavonoids of Fructus Aurantii Immaturus in functional dyspepsia (FD) (4 arms), sponsored by Jiangxi Qingfeng Pharmaceutical Co. Ltd. Primary endpoints: Disappearance rate of four functional dyspepsia symptoms after 4 weeks, Symptom score for postprandial fullness, early satiation, and epigastric burning and 1 more. Started Oct 2011; status: completed.
02
Drugs
Total Flavonoids of Fructus Aurantii Immaturus
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ISRCTN10266781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10266781.